Due Diligence Content Update
Some bad news.
Good morning, dear readers.
Unfortunately, we have some bad news — we don’t have a Due Diligence report for you today.
Our day jobs got in the way, and we had to deal with some COVID-19 hurdles. (If you haven’t gotten your vaccine already, assume the symptoms will knock you out for a couple of days.)
But, we do have something for you: an upcoming content schedule so that you know exactly what’s in our pipeline.
May 14, 2021: Pfizer Report
May 21, 2021: Market Movers #2
May 28, 2021: Cresco Labs Report
June 04, 2021: Market Movers #3
June 11, 2021: ChargePoint Report
We’ll be back on schedule next As always, you can find previous editions of our newsletter here. Be on the lookout for our analysis of Pfizer next week!
The Due Diligence Team